What Is Renal Cell Carcinoma Symptoms Stages Survival?

Renal cell carcinoma is the most common type of kidney cancer in adults, accounting for roughly 9 out of 10 kidney cancers. It starts in the tiny tubes inside the kidney that filter blood and make urine. Many cases are found by accident on imaging done for other reasons, before any symptoms appear. When it is caught while still confined to the kidney, survival rates are high. Once it spreads beyond the kidney, treatment becomes harder and survival drops.

What Is Renal Cell Carcinoma?

Renal cell carcinoma begins in the renal cortex, the outer part of the kidney. The cells that line the small filtering tubes there can grow out of control and form a mass.

There are several subtypes. Clear cell is the most common, making up about 75 percent of cases. Papillary and chromophobe are the next most frequent. Each subtype behaves somewhat differently and can respond differently to treatment.

This cancer is different from other growths that can appear in the kidney. Benign tumors like oncocytoma are not cancer. Urothelial carcinoma, which starts in the lining of the kidney’s drainage system, is a separate disease with its own treatment.

One detail that surprises many people: renal cell carcinoma does not always cause blood in the urine or pain. In fact, most cases today are found before any of those symptoms develop, usually during an ultrasound, CT scan, or MRI done for an unrelated problem.

What Are the Symptoms of Renal Cell Carcinoma?

Early kidney cancer often causes no symptoms at all. That is why it is frequently called a silent disease in its early stages.

When symptoms do appear, they can include:

• Blood in the urine, which may make it look pink, red, or cola-colored
• A lump or mass felt in the side or lower back
• Pain in the side or back that does not go away
• Unexplained weight loss
• Fever that comes and goes
• Feeling very tired
• Loss of appetite
• Swelling in the legs or ankles

A classic triad of symptoms — blood in the urine, flank pain, and a palpable mass — was once taught as the hallmark of kidney cancer. In practice, fewer than 1 in 10 people with renal cell carcinoma have all three at diagnosis. Most have only one, or none.

Some people develop paraneoplastic symptoms, meaning symptoms caused by the cancer’s effects on the body rather than by the tumor pressing on anything. These can include high blood pressure, high calcium levels, or a condition called Stauffer syndrome, where liver function tests become abnormal even though the liver itself is fine.

These symptoms overlap with many common conditions. Blood in the urine, for example, can come from a urinary tract infection, kidney stones, or bladder problems. Having these symptoms does not mean you have kidney cancer, but they do warrant a medical evaluation.

What Are the Stages of Renal Cell Carcinoma?

Staging describes how far the cancer has spread. It guides treatment and helps estimate prognosis.

Renal cell carcinoma is staged using the TNM system, which looks at the tumor, nearby lymph nodes, and distant spread. These are grouped into four stages:

• Stage I: The tumor is 7 cm or smaller and confined to the kidney.
• Stage II: The tumor is larger than 7 cm but still confined to the kidney.
• Stage III: The tumor has grown into major veins, the tissue around the kidney, or nearby lymph nodes.
• Stage IV: The cancer has spread to distant organs such as the lungs, bones, liver, or brain, or it has grown into the adrenal gland or beyond the kidney’s surrounding fascia.

About 1 in 3 cases are already advanced at diagnosis. That is partly because early disease causes so few symptoms.

What Is the Survival Rate for Renal Cell Carcinoma?

Survival statistics are usually expressed as a five-year relative survival rate. This is the percentage of people still alive five years after diagnosis compared with people of the same age without the cancer. It does not tell you how long any one person will live.

Based on data collected by the National Cancer Institute’s Surveillance, Epidemiology, and End Results program, the five-year relative survival rate for kidney cancer overall is about 77 percent. When the cancer is confined to the kidney, that figure rises to roughly 93 percent. When it has spread to nearby lymph nodes or surrounding tissue, it drops to about 71 percent. Once it has spread to distant organs, it falls to around 18 percent.

These numbers reflect people diagnosed between 2014 and 2020, before several newer treatments became widely used. They also include all kidney cancers, not only renal cell carcinoma. Survival rates for renal cell carcinoma specifically may differ slightly.

It is important to understand what these numbers mean and what they do not. They describe large groups of people, not individuals. A person’s outlook depends on their age, general health, the specific subtype of cancer, how well it responds to treatment, and many other factors.

Some studies suggest that outcomes have been improving over time, partly because more early-stage cancers are being detected and partly because of better treatments for advanced disease. But current five-year figures for advanced disease remain low.

How Is Renal Cell Carcinoma Treated?

Treatment depends heavily on the stage and the person’s overall health.

For localized disease — stages I through III — surgery is the main treatment. The goal is to remove the cancer while preserving as much kidney function as possible.

Options include:

• Partial nephrectomy: Removing just the tumor and a margin of healthy tissue. This is often preferred when technically feasible because it preserves more kidney function.
• Radical nephrectomy: Removing the entire kidney, and sometimes nearby tissue or lymph nodes.
• Ablation: Using heat or cold to destroy small tumors. This is typically reserved for people who cannot have surgery.
• Active surveillance: Monitoring small tumors with regular imaging. This is sometimes used for older adults or those with other serious health problems.

For advanced or metastatic disease, treatment is different. Surgery may still play a role in removing the primary tumor, but systemic therapy is the main approach.

Systemic treatments include:

• Immune checkpoint inhibitors: Drugs that help the immune system attack cancer cells. These have become a standard first-line treatment for advanced disease, often given in combination.
• Targeted therapy: Drugs that block specific molecules involved in cancer growth, such as those in the VEGF pathway.
• Combination therapy: Pairing an immune checkpoint inhibitor with another immune drug or a targeted therapy.

Radiation therapy is used less often for kidney cancer than for many other cancers, but it can help control symptoms from tumors that have spread to bones or the brain.

The evidence supporting immune checkpoint inhibitors and targeted therapies for advanced renal cell carcinoma is substantial. Multiple randomized trials have shown they improve survival compared with older treatments. That said, not everyone responds, and these drugs carry significant side effects.

What Causes Renal Cell Carcinoma and Who Is at Risk?

The exact cause of most kidney cancers is not known. What is clear is that certain factors increase risk.

Established risk factors include:

• Smoking: This roughly doubles the risk and is one of the strongest modifiable factors.
• Obesity: Higher body weight is linked to increased risk.
• High blood pressure: Even when controlled with medication, hypertension is associated with higher risk.
• Age: Risk rises with age, with most cases diagnosed after age 60.
• Sex: Men are about twice as likely as women to develop it.
• Family history: Having a close relative with kidney cancer raises risk.
• Certain genetic conditions: von Hippel-Lindau disease, Birt-Hogg-Dubé syndrome, and hereditary papillary renal cell carcinoma are linked to higher risk.
• Long-term dialysis: People on dialysis for many years have an increased risk.
• Occupational exposures: Some industrial chemicals, including certain solvents and heavy metals, have been associated with kidney cancer.

Some commonly mentioned factors have weaker or inconsistent evidence. Diet, for example, has been studied extensively, but no single food or nutrient has been convincingly shown to cause or prevent kidney cancer.

Having one or more risk factors does not mean you will get kidney cancer. Many people with these factors never develop it, and some people with no known risk factors do.

Can Renal Cell Carcinoma Be Prevented?

There is no proven way to prevent renal cell carcinoma. But some steps may lower risk.

Not smoking, maintaining a healthy weight, and controlling blood pressure are all associated with lower risk. These are also good for overall health.

For people with inherited conditions that raise kidney cancer risk, regular screening with imaging may be recommended. The evidence for screening in the general population is not strong enough to support routine imaging for everyone.

If you have symptoms that could suggest kidney cancer — especially blood in the urine — see a doctor. Early detection matters because treatment is most effective when the cancer is still confined to the kidney.